Related Experiment Video
Updated: Jul 29, 2025
06:46
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
2.8K
Diabetes, COVID-19, and questions unsolved
Felecia D'Souza1,2, Raffaella Buzzetti3, Paolo Pozzilli4,5
1University College London Hospitals NHS Trust, London, UK.
Diabetes/Metabolism Research and Reviews
|May 20, 2023
Summary
People with diabetes face higher risks from COVID-19 infection and its complications. Vaccination is recommended for this high-risk group, alongside optimizing blood sugar control for better protection.
Area of Science:
- Endocrinology and Infectious Diseases
- Immunology and Virology
Background:
- Diabetes Mellitus is increasingly linked to severe COVID-19 outcomes.
- Understanding the mechanisms and vaccine efficacy in diabetics is crucial.
Purpose of the Study:
- To investigate diabetes as an accelerator of adverse COVID-19 outcomes.
- To explore mechanisms underlying COVID-19 severity in diabetic patients.
- To assess the efficacy of COVID-19 vaccines in individuals with diabetes.
Main Methods:
- Comprehensive literature search on diabetes and COVID-19.
- Analysis of peer-reviewed studies addressing key research questions.
Main Results:
- Diabetes significantly increases the risk of adverse COVID-19 outcomes and post-COVID sequelae.
- Potential mechanisms include ACE2/Furin/CD147 dysregulation and impaired immune response, exacerbated by hyperglycemia.
- Current evidence suggests COVID-19 vaccines are protective for people with diabetes.
Conclusions:
- Individuals with diabetes are a high-risk group for COVID-19 and should be prioritized for vaccination.
- Glycemic control is essential for mitigating COVID-19 risks in diabetic populations.
- Further research is needed on molecular mechanisms, long-term vaccine efficacy, and post-COVID symptom management in diabetics.
